sec filing
PR
NASDAQ · PRLD
Prelude Therapeutics Incorporated
Healthcare · Biotechnology
$3.88
Down-$0.22 (-5.37%)
Updated Nov 1, 2026, 10:44 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 89.12M
- P/E ratio
- -0.99
- Dividend yield
- 0.00%
- 52-week range
- $1.17 – $6.83
- Volume
- 218.1K
- Avg. volume
- 1.38M
Price performance · PRLD
PRLD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PRLD closed at $3.88 after 20 trading sessions, up 2.92% for the selected period.
- Last close
- $3.88
- Period change
- +2.92%
- Period low
- $3.23
- Period high
- $4.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.02 | $4.105 | $3.82 | $3.88 | 218.1K |
| Oct 29, 2026 | $4.16 | $4.25 | $4.07 | $4.10 | 201.32K |
| Oct 28, 2026 | $3.89 | $4.16 | $3.79 | $4.14 | 475.87K |
| Oct 27, 2026 | $3.70 | $3.94 | $3.60 | $3.88 | 277.48K |
| Oct 26, 2026 | $3.63 | $3.74 | $3.40 | $3.70 | 236.86K |
| Oct 23, 2026 | $3.59 | $3.69 | $3.41 | $3.63 | 288.58K |
| Oct 22, 2026 | $3.61 | $3.73 | $3.47 | $3.60 | 323.76K |
| Oct 21, 2026 | $3.56 | $3.78 | $3.4732 | $3.65 | 608.33K |
| Oct 20, 2026 | $3.40 | $3.61 | $3.35 | $3.53 | 362.77K |
| Oct 19, 2026 | $3.28 | $3.42 | $3.26 | $3.39 | 1.59M |
| Oct 16, 2026 | $3.32 | $3.41 | $3.18 | $3.26 | 479.87K |
| Oct 15, 2026 | $3.30 | $3.44 | $3.20 | $3.32 | 400.25K |
| Oct 14, 2026 | $3.50 | $3.50 | $3.205 | $3.23 | 489.01K |
| Oct 13, 2026 | $3.74 | $3.897 | $3.43 | $3.56 | 676.36K |
| Oct 12, 2026 | $3.91 | $3.94 | $3.74 | $3.74 | 196.55K |
| Oct 9, 2026 | $3.87 | $4.03 | $3.85 | $3.89 | 341.65K |
| Oct 8, 2026 | $3.77 | $3.95 | $3.66 | $3.88 | 424.1K |
| Oct 7, 2026 | $3.835 | $3.93 | $3.69 | $3.83 | 454.7K |
| Oct 6, 2026 | $3.78 | $3.82 | $3.68 | $3.81 | 383.74K |
| Oct 5, 2026 | $3.68 | $3.81 | $3.55 | $3.77 | 325.28K |
Latest PRLD news
The latest Smart Investors Daily articles mentioning PRLD.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

